Phase 3 trial of Sinovac's Sabin-inactivated poliovirus vaccine in China
Phase of Trial: Phase III
Latest Information Update: 22 Nov 2017
At a glance
- Drugs Poliovirus vaccine Intravacc/WHO (Primary)
- Indications Poliomyelitis
- Focus Adverse reactions; Therapeutic Use
- 22 Nov 2017 According to a Sinovac Biotech media release, this trial was initiated in the third quarter of 2017 and expected to be completed in 2018.
- 22 Nov 2017 Status changed from planning to recruiting, as reported in a Sinovac Biotech media release.
- 08 Nov 2016 New trial record